Days after approving a $150 million class action settlement between direct purchasers of nasal spray Flonase and manufacturer GlaxoSmithKline, a federal judge has approved a $35 million settlement between GSK and the indirect purchasers of the drug.
In approving the $35 million settlement in In re Flonase Antitrust Litigation, U.S. District Senior Judge Anita B. Brody of the Eastern District of Pennsylvania also awarded nearly $11.7 million in attorney fees and $1.85 million in expenses to the plaintiffs' class counsel. Fifteen firms worked on the case with lead counsel Miller Law and Pomerantz Grossman Hufford Dahlstrom & Gross logging the majority of the 37,762 hours worked over the nearly five years of litigation.
